| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f04d319aaa6e66f240244bc905f452 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0621 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-079 |
| filingDate |
2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1ef766983ef598b4284b2c9bd2db82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_828bcad2dc36b8754cf2b8143615047f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b41adc8e91c10b86f51baeb6bdf822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f51686ef476aa5bd01f861b2fa2b826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7914d53ed08c6ecf35555e93647aa4e1 |
| publicationDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10301591-B2 |
| titleOfInvention |
Method for differentiation into biocompatible keratocyte progenitor cells and keratocyte progenitor cell composition |
| abstract |
Disclosed is a method for differentiation into biocompatible keratocyte progenitor cells, the method including: providing human turbinate mesenchymal stem cells (hTMSCs) from a tissue source; and culturing the provided human turbinate mesenchymal stem cells (hTMSCs) in a keratocyte differentiation medium supplemented with keratocyte growth factor (KGF), so that a differentiable keratocyte precursor cell composition that is impossible in the conventional art can be implemented, and the injection of the keratocyte progenitor cell composition into patients can produce a short-term treatment effect while securing the transparency of the cornea. |
| priorityDate |
2015-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |